Because so many questions exist about safety, efficacy, long-term effects and more, ASAM appropriately invited several scientists and clinicians to present the latest data on the role of GLP-1 RAs in addiction
However, improving the therapeutic window of natural hepatoprotective agents, developing drug carriers with excellent properties, and reducing their toxicity remain current and future problems to be overcome
All procedures should be discussed with qualified medical professionals
[DOI] [PubMed] [Google Scholar] 229.Martell A.E., Smith R.M
Most patients notice reduced appetite within the first few weeks
They may involve a primitive brain mechanism similar to the freezing of some animals when presented with an inescapable danger